title: Aggrecan- and COMP-loaded poly-(lactic-co-glycolic acid) nanoparticles stimulate chondrogenic differentiation of human mesenchymal stem cells.
abstract: During embryogenesis, specific proteins expressed in cells have key roles in the formation of differentiated cells and tissues. Delivery of specific proteins into specific cells, both in vitro and in vivo, has proved to be exceedingly difficult. In this study, we developed a safe and efficient protein delivery system using encapsulation of proteins into biodegradable poly-(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs). The PLGA NPs were used to deliver proteins into human mesenchymal stem cells (hMSCs). Fluorescent markers loaded into the PLGA NPs were used to verify the internalization of NPs into hMSCs using FACS analysis and confocal microscopy. With these methods, we demonstrated that the encapsulated model proteins are readily delivered into hMSCs, released from the NP vehicles, and, finally, moved into the cytosols. Using chondrogenesis-related proteins such as aggrecan and cartilage oligomeric matrix protein (COMP), chondrogenic differentiation of hMSCs treated with aggrecan and COMP encapsulated PLGA NPs was clearly observed and caused to differentiate into chondrocytes.
authors.affiliation: 1 Department of Biomedical Science, College of Life Science, CHA University , Seongnam-si, Republic of Korea.
authors.forename: Su Yeon
authors.initials: SY
authors.lastname: Jeon
authors.forename: Ji Sun
authors.initials: JS
authors.lastname: Park
authors.forename: Han Na
authors.initials: HN
authors.lastname: Yang
authors.forename: Dae Gyun
authors.initials: DG
authors.lastname: Woo
authors.forename: Keun-Hong
authors.initials: KH
authors.lastname: Park
mesh_terms: D053674:Aggrecans / Q000494:pharmacology*; D001692:Biological Transport; D064236:Cartilage Oligomeric Matrix Protein / Q000494:pharmacology*; D002454:Cell Differentiation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D019902:Chondrocytes / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D020219:Chondrogenesis; D004337:Drug Carriers; D004339:Drug Compounding; D005260:Female; D005456:Fluorescent Dyes; D005786:Gene Expression Regulation; D006801:Humans; D019344:Lactic Acid / Q000737:chemistry*; D059630:Mesenchymal Stem Cells / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D008751:Methylene Blue / Q000031:analogs & derivatives; D053758:Nanoparticles / Q000737:chemistry*; D011100:Polyglycolic Acid / Q000737:chemistry*; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D061251:Primary Cell Culture; D015398:Signal Transduction; D055815:Young Adult
chemical_list: D053674:Aggrecans; D064236:Cartilage Oligomeric Matrix Protein; D004337:Drug Carriers; D005456:Fluorescent Dyes; D019344:Lactic Acid; D008751:Methylene Blue; D011100:Polyglycolic Acid; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; C435946:dimethylmethylene blue; C577553:TSP5 protein, human